• Je něco špatně v tomto záznamu ?

Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats

V Kummer, J Maskova, Z Zraly, J Neca, P Simeckova, J Vondracek, M Machala

. 2008 ; 180 (3) : 212-221.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006826
E-zdroje Online

NLK ScienceDirect (archiv) od 1993-01-01 do 2009-12-31

Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.

000      
04104naa 2200541 a 4500
001      
bmc11006826
003      
CZ-PrNML
005      
20111210203342.0
008      
110406s2008 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kummer, Vladimír. $7 _AN049159
245    10
$a Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats / $c V Kummer, J Maskova, Z Zraly, J Neca, P Simeckova, J Vondracek, M Machala
314    __
$a Veterinary Research Institute, Brno 62132, Czech Republic.
520    9_
$a Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.
650    _2
$a zvířata $7 D000818
650    _2
$a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
650    _2
$a endokrinní disruptory $x toxicita $7 D052244
650    _2
$a látky znečišťující životní prostředí $x toxicita $7 D004785
650    _2
$a epitel $x účinky léků $7 D004848
650    _2
$a estradiol $x metabolismus $7 D004958
650    _2
$a alfa receptor estrogenů $x metabolismus $7 D047628
650    _2
$a estrogeny $x biosyntéza $7 D004967
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hydroxylace $7 D006900
650    _2
$a imunohistochemie $7 D007150
650    _2
$a jaterní mikrozomy $x metabolismus $x účinky léků $7 D008862
650    _2
$a velikost orgánu $x účinky léků $7 D009929
650    _2
$a ovarium $x účinky léků $7 D010053
650    _2
$a fosforylace $7 D010766
650    _2
$a polycyklické aromatické uhlovodíky $x toxicita $7 D011084
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
650    _2
$a uterus $x metabolismus $x účinky léků $7 D014599
650    _2
$a financování organizované $7 D005381
700    1_
$a Mašková, Jarmila. $7 _AN050260
700    1_
$a Zralý, Zdeněk. $7 uzp2009545475
700    1_
$a Neča, Jiří $7 xx0079512
700    1_
$a Šimečková, Pavlína. $7 xx0221392
700    1_
$a Vondráček, Jan, $d 1970- $7 xx0137878
700    1_
$a Machala, Miroslav $7 xx0094277
773    0_
$t Toxicology Letters $w MED00004537 $g Roč. 180, č. 3 (2008), s. 212-221 $x 0378-4274
910    __
$a ABA008 $b x $y 7
990    __
$a 20110412131138 $b ABA008
991    __
$a 20110817123445 $b ABA008
999    __
$a ok $b bmc $g 834443 $s 698945
BAS    __
$a 3
BMC    __
$a 2008 $b 180 $c 3 $d 212-221 $i 0378-4274 $m Toxicology letters $n Toxicol Lett $x MED00004537
LZP    __
$a 2011-4B/ewme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...